Navigation Links
Studies assess genetics, modified treatment to improve outcomes, reduce toxicity
Date:12/8/2012

RAC2, and HFE genes had up to a three-fold higher risk of developing heart failure after transplant; these genes are responsible for key proteins that regulate the metabolism of anthracyclines and defense against oxidative stress. Females with two or more genetic variations were at the highest risk of developing the conditions when compared to males with one or none of these variations. The discovery of these genetic variations supplements previously identified clinical variables known to affect a transplant survivor's heart health.

"Following this study we now have a much better profile of those transplant survivors who are likely to develop heart failure," said Saro Armenian, DO, MPH, lead author and Assistant Professor in the Division of Outcomes Research and Medical Director of the Pediatric Survivorship Clinic in the Childhood Cancer Survivorship Program at City of Hope in Duarte, Calif. "Armed with these insights, we can now create better screening measures and perhaps even tailor intervention strategies based on a patients' genetic makeup, minimizing long-term transplant-related toxicity and making a tremendous difference in the long-term health of these patients."

Dr. Armenian will present this study in an oral presentation on Monday, December 10, at 2:45 p.m. EST at the Georgia World Congress Center in Room C108-C109, Level 1, Building C.

Daunorubicin or Not During the Induction Treatment of Childhood Standard-Risk B-Cell Precursor Acute Lymphoblastic Leukemia (SR-BCP-ALL): The Randomized Fralle 2000-A Protocol[Abstract 135]

New data demonstrate that omitting the chemotherapy drug daunorubicin from an initial treatment regimen for children with standard-risk acute lymphocytic leukemia (ALL) does not reduce survival outcomes, suggesting that these children may be able to achieve positive outcomes without having to endure
'/>"/>

Contact: Andrea Slesinski
aslesinski@hematology.org
614-352-5096
American Society of Hematology
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. John Theurer Cancer Center to present 37 studies at the 2012 ASH Annual Meeting
2. Benefit6 Whole Body Protection, a New Product by I Do Strive LLC, Provides Increased Energy Production According to Recent Studies
3. Sharp spike in computer-related injuries predicted for medical workers, find studies
4. Analysis of conflicting fish oil studies finds that omega-3 fatty acids still matter
5. Studies from 2012 Quality Care Symposium highlight findings in improving quality of cancer care
6. New studies show effects of mammography guideline changes
7. 2 NIH studies show power of epidemiology research; Underscore need to address health disparities
8. Scripps studies show community-based diabetes programs are key to lowered costs and improved care
9. Cancer Drug Reduced Relapses in MS Patients: Studies
10. University of Houston India Studies Program presents Circuits of Empire: India as Metropole
11. Studies Show Limits, Promise of Laser Removal of Tattoos
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... Aliso Viejo, CA (PRWEB) May 27, 2015 ... from Pixel Film Studios, editors can quickly and easily add ... 60 cross processed CUBE LUT files. , FCPX LUT Cross ... look from vintage to contemporary looks and everything in between. ... and they can be used in many different softwares. With ...
(Date:5/27/2015)... The Case Management Society of America ... CMSA Lifetime Achievement Award, to Anne Llewellyn RN-BC, MS, ... 25th at the association’s 25th Annual Conference and Expo ... The CMSA Board of Directors awards the Lifetime Achievement ... significant contribution to practice of case management and in ...
(Date:5/27/2015)... This year, Mental Health America (MHA) ... those affected to seek assistance before a crisis occurs. According ... in five children, ages 13 to 18, are living with ... cases of mental illness within one's lifetime will begin by ... seek help before reaching a critical stage — particularly for ...
(Date:5/27/2015)... According to research conducted by Dr. ... at Dallas some migraine patients have an increased likelihood ... headache apparently also have some shared risk factors -- ... with a history of diabetes and/or smoking. Both conditions ... CTS in particular was less common in Hispanics. ...
(Date:5/26/2015)... 27, 2015 Avid Collector, Andrew ... search for original Jimi Hendrix January 11-23, 1969 psychedelic German ... "medusa" image of Hendrix for this concert poster ... is also known as the Hendrix with wired ... over twelve days. The tour started at the ...
Breaking Medicine News(10 mins):Health News:Developers at Pixel Film Studios Release FCPX LUT Cross Processed Plugin for Final Cut Pro X 2Health News:CMSA to Present Prestigious Lifetime Achievement Award to Anne Llewellyn RN-BC, MS, BHSA, CCM, CRRN 2Health News:The Glenholme School Observes Mental Health Awareness Month 2Health News:The Glenholme School Observes Mental Health Awareness Month 3Health News:Santa Rosa Orthopaedics Offers Insights into Recent Study Results Connecting Migraines with Chronic Conditions Such as Carpal Tunnel Syndrome 2Health News:Santa Rosa Orthopaedics Offers Insights into Recent Study Results Connecting Migraines with Chronic Conditions Such as Carpal Tunnel Syndrome 3Health News:Santa Rosa Orthopaedics Offers Insights into Recent Study Results Connecting Migraines with Chronic Conditions Such as Carpal Tunnel Syndrome 4Health News:Avid Collector from Vintage Rock Posters Announces His Search for Original Jimi Hendrix January 11-23, 1969 Psychedelic German Concert Tour Posters 2
... Sept. 2 Danaher Corporation (NYSE: DHR ) ... MDS Inc. (TSX: MDS; NYSE: MDZ ) to ... 50% ownership position in Applied Biosystems/MDS Sciex joint venture ("AB ... in the former Molecular Devices Corporation, a bioresearch and analytical ...
... , , PRINCETON, N.J., ... of Ranbaxy Laboratories Limited (RLL), Gurgaon, India, announced an agreement with ... version of Rocaltrol(R) (calcitriol) in both softgel capsules and an oral ... oral liquid were $70 million (IMS - MAT: June 2009). ...
... , CINCINNATI, Sept. 2 LCA-Vision Inc. (Nasdaq: ... under the Lasik Plus ((R)) brand, today announced that members of its ... , , FTN Equity Capital ... Wednesday, September 2 at the Grand Hyatt Hotel in New York City; ...
... , LONDON, Sept. 2 Although most ... place, very few have a fully integrated and functional hospital ... solutions in 2008 in Europe varied from about 73.0 per ... Scandinavia. Increasing accountability pressures on the government and regulatory authorities ...
... ... ... Jackson & Coker has named David Booher as Vice President of Jackson & Coker,s ... be a very capable leader in our accounting and finance department, and his well-rounded abilities ...
... ... traveling with diabetes to raise diabetes awareness around the world, and proving that there ... , ... South Africa (PRWEB) September 2, 2009 -- Novelist, Bridget McNulty, and photographer, Mark Peddle, ...
Cached Medicine News:Health News:Danaher to Acquire Life Sciences Instrumentation Businesses From MDS Inc. and Life Technologies Corporation 2Health News:Danaher to Acquire Life Sciences Instrumentation Businesses From MDS Inc. and Life Technologies Corporation 3Health News:Danaher to Acquire Life Sciences Instrumentation Businesses From MDS Inc. and Life Technologies Corporation 4Health News:Ranbaxy Launches Authorized Generic Version of Rocaltrol(R) 2Health News:Ranbaxy Launches Authorized Generic Version of Rocaltrol(R) 3Health News:LCA-Vision to Present at September Investment Conferences 2Health News:Added Investment Into Healthcare By the Government Drives Growth in the European Hospital Information Systems Market, Notes Frost & Sullivan 2Health News:Added Investment Into Healthcare By the Government Drives Growth in the European Hospital Information Systems Market, Notes Frost & Sullivan 3Health News:Jackson & Coker Names David Booher Vice President of Emergency Medicine Recruitment 2Health News:Traveling With Diabetes The Positive Way 2Health News:Traveling With Diabetes The Positive Way 3
(Date:5/27/2015)... May 27, 2015 Mapi Pharma Ltd. ... of $10 million in the company in a Series A ... CEO Mr. Ehud Marom . The funding will be ... is sufficient to advance the company,s lead product, the Glatiramer ... at Phase II, up to the initiation of the single ...
(Date:5/27/2015)... Colo., May 27, 2015 Encision Inc. (OTCQB:ECIA), ... prevents dangerous stray electrosurgical burns in minimally invasive surgery, ... quarter and fiscal year ended March 31, 2015. ... million for a quarterly net loss of $349 thousand, ... revenue of $2.504 million for a net loss of ...
(Date:5/27/2015)... May 27, 2015  The World MS Day campaign ... organizations globally to raise awareness of multiple sclerosis and those ... and support that will move us closer a world ... circling the globe, including the National MS Society, have ... The 2015 World MS Day campaign theme is "access." ...
Breaking Medicine Technology:Mapi Pharma Closes $10 Million Investment Led by Shavit Capital 2Encision Reports Fourth Quarter And Fiscal Year 2015 Results 2Encision Reports Fourth Quarter And Fiscal Year 2015 Results 3Encision Reports Fourth Quarter And Fiscal Year 2015 Results 4Encision Reports Fourth Quarter And Fiscal Year 2015 Results 5Encision Reports Fourth Quarter And Fiscal Year 2015 Results 6People Around The World Are Sharing What Makes Them Stronger Than Multiple Sclerosis 2People Around The World Are Sharing What Makes Them Stronger Than Multiple Sclerosis 3People Around The World Are Sharing What Makes Them Stronger Than Multiple Sclerosis 4People Around The World Are Sharing What Makes Them Stronger Than Multiple Sclerosis 5
... BEIJING, Nov. 9, 2011 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. ... biopharmaceutical products in China, announced today the positive top-line ... proprietary inactivated vaccine against human enterovirus 71 (EV71), which ... Phase II results for the EV71 vaccine showed a ...
... HARBIN, China, Nov. 9, 2011 /PRNewswire-Asia/ -- China Sky One ... CSKI ), a leading fully integrated pharmaceutical company producing ... announced financial results for the third quarter of 2011. ... Financial Highlights , Total revenues decreased 26.6% year-over-year to ...
Cached Medicine Technology:Sinovac Reports Positive Preliminary Phase II Clinical Trial Results for EV71 Vaccine Against Hand, Foot and Mouth Disease 2Sinovac Reports Positive Preliminary Phase II Clinical Trial Results for EV71 Vaccine Against Hand, Foot and Mouth Disease 3Sinovac Reports Positive Preliminary Phase II Clinical Trial Results for EV71 Vaccine Against Hand, Foot and Mouth Disease 4China Sky One Medical Announces Third Quarter 2011 Results 2China Sky One Medical Announces Third Quarter 2011 Results 3China Sky One Medical Announces Third Quarter 2011 Results 4China Sky One Medical Announces Third Quarter 2011 Results 5China Sky One Medical Announces Third Quarter 2011 Results 6China Sky One Medical Announces Third Quarter 2011 Results 7China Sky One Medical Announces Third Quarter 2011 Results 8China Sky One Medical Announces Third Quarter 2011 Results 9China Sky One Medical Announces Third Quarter 2011 Results 10China Sky One Medical Announces Third Quarter 2011 Results 11China Sky One Medical Announces Third Quarter 2011 Results 12China Sky One Medical Announces Third Quarter 2011 Results 13China Sky One Medical Announces Third Quarter 2011 Results 14China Sky One Medical Announces Third Quarter 2011 Results 15China Sky One Medical Announces Third Quarter 2011 Results 16China Sky One Medical Announces Third Quarter 2011 Results 17China Sky One Medical Announces Third Quarter 2011 Results 18
... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
... is an excellent choice to treat arthritic pain, ... or following cast removal. The durable canvas ... and compression to the wrist to help relieve ... splint prevents painful wrist flexion, and holds the ...
... for controlling range of motion of the ... known for its lower extremity bracing solutions, ... patients have benefitted from our custom and ... ROM Series post-operative elbow braces come in ...
... The new "Innovation Joint Technology" elbow brace ... medical specialists to help re-establish pain free ... Brace has been engineered to provide the ... dynamic rotation forces. Treatment use includes Wrist ...
Medicine Products: